SCHEDULE: Valiant Capital Discloses 5.1% Stake in Core Scientific

Valiant Capital Management, L.P. and Christopher R. Hansen have reported a 5.1% beneficial ownership stake in Core Scientific, Inc. common stock.

Summary

• Valiant Capital Management, L.P., Valiant Capital Management, LLC, and Christopher R. Hansen have filed a Schedule 13G indicating a collective beneficial ownership of 16,213,103 shares of Core Scientific, Inc. common stock.
• The reported stake represents 5.1% of the company's total outstanding common stock, based on 317,885,292 shares outstanding as of May 1, 2026.
• The reporting persons share voting and dispositive power over the entire 16,213,103 share position.
• The filing confirms the acquisition was made in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine regulatory disclosure indicating institutional interest without signaling an activist agenda.

Positives

• Institutional investor confidence demonstrated by the accumulation of a significant 5.1% equity position.
• The filing confirms the investment is passive in nature, suggesting no immediate intent to disrupt corporate strategy or management.

Negatives

• None identified in this regulatory disclosure.

Risks

• Market volatility associated with the underlying common stock of Core Scientific, Inc.
• Potential for future changes in investment strategy by the reporting persons.

Future Outlook

The filing does not provide forward-looking guidance regarding the issuer's operations, but confirms the reporting persons' intent to hold the securities in the ordinary course of business.

Management Comments

• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that institutional 13G filings are standard disclosures for investment firms crossing the 5% ownership threshold. This activity is consistent with broader trends of institutional capital allocation into the digital infrastructure and blockchain mining sector.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for beneficial ownership reporting.
• The passive investment classification is consistent with typical hedge fund portfolio management practices for non-activist positions.

Stakeholder Impact

• Shareholders may view the entry of a significant institutional investor as a validation of the company's long-term prospects.

Next Steps

• The reporting persons are required to file amendments to this Schedule 13G if there are any material changes in the percentage of ownership.

Key Dates

Keywords

Core Scientific, Valiant Capital, Schedule 13G, Institutional Ownership, Common Stock, Christopher R. Hansen